226 related articles for article (PubMed ID: 21339183)
1. Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.
Gao Y; Mengana Y; Cruz YR; Muñoz A; Testé IS; García JD; Wu Y; Rodríguez JC; Zhang C
J Histochem Cytochem; 2011 Feb; 59(2):214-27. PubMed ID: 21339183
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin offers neuroprotection through inducing endogenous erythropoietin receptor and neuroglobin in a neonatal rat model of periventricular white matter damage.
Zhu L; Huang L; Wen Q; Wang T; Qiao L; Jiang L
Neurosci Lett; 2017 May; 650():12-17. PubMed ID: 28359933
[TBL] [Abstract][Full Text] [Related]
3. Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats.
Castañeda-Arellano R; Feria-Velasco AI; Rivera-Cervantes MC
Neurosci Lett; 2014 Nov; 583():16-20. PubMed ID: 25219375
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.
Xiong Y; Mahmood A; Qu C; Kazmi H; Zhang ZG; Noguchi CT; Schallert T; Chopp M
J Neurotrauma; 2010 Jan; 27(1):205-15. PubMed ID: 19715391
[TBL] [Abstract][Full Text] [Related]
5. Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia.
Rodríguez Cruz Y; Mengana Támos Y; Muñoz Cernuda A; Subirós Martines N; González-Quevedo A; Sosa Testé I; García Rodríguez JC
ScientificWorldJournal; 2010 Nov; 10():2288-300. PubMed ID: 21103798
[TBL] [Abstract][Full Text] [Related]
6. Nonhematopoietic variants of erythropoietin in ischemic stroke: need for step-wise proof-of-concept studies.
Hermann DM
ScientificWorldJournal; 2010 Nov; 10():2285-7. PubMed ID: 21103797
[TBL] [Abstract][Full Text] [Related]
7. Increased neuroglobin levels in the cerebral cortex and serum after ischemia-reperfusion insults.
Shang A; Zhou D; Wang L; Gao Y; Fan M; Wang X; Zhou R; Zhang C
Brain Res; 2006 Mar; 1078(1):219-26. PubMed ID: 16492379
[TBL] [Abstract][Full Text] [Related]
8. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
9. Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil.
Teste IS; Tamos YM; Cruz YR; Cernada AM; Rodríguez JC; Martínez NS; Antich RM; González-Quevedo A; Rodríguez JC
ScientificWorldJournal; 2012; 2012():607498. PubMed ID: 22701364
[TBL] [Abstract][Full Text] [Related]
10. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
Garcia-Rodriguez JC; Sosa-Teste I
ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
[TBL] [Abstract][Full Text] [Related]
11. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats.
Macias-Velez RJ; Fukushima-Díaz de León L; Beas-Zárate C; Rivera-Cervantes MC
J Mol Neurosci; 2019 Aug; 68(4):590-602. PubMed ID: 31054091
[TBL] [Abstract][Full Text] [Related]
13. Hemin‑mediated neuroglobin induction exerts neuroprotection following ischemic brain injury through PI3K/Akt signaling.
Zhang B; Ji X; Zhang S; Ren H; Wang M; Guo C; Li Y
Mol Med Rep; 2013 Aug; 8(2):681-5. PubMed ID: 23765006
[TBL] [Abstract][Full Text] [Related]
14. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
15. Neuroglobin protects neurons against oxidative stress in global ischemia.
Li RC; Guo SZ; Lee SK; Gozal D
J Cereb Blood Flow Metab; 2010 Nov; 30(11):1874-82. PubMed ID: 20571522
[TBL] [Abstract][Full Text] [Related]
16. Neuroglobin over expressing mice: expression pattern and effect on brain ischemic infarct size.
Raida Z; Hundahl CA; Nyengaard JR; Hay-Schmidt A
PLoS One; 2013; 8(10):e76565. PubMed ID: 24098534
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms.
Zhang F; Signore AP; Zhou Z; Wang S; Cao G; Chen J
J Neurosci Res; 2006 May; 83(7):1241-51. PubMed ID: 16511866
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia.
Wang X; Liu J; Zhu H; Tejima E; Tsuji K; Murata Y; Atochin DN; Huang PL; Zhang C; Lo EH
Stroke; 2008 Jun; 39(6):1869-74. PubMed ID: 18403737
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence that erythropoietin protects neurons from ischemic damage.
Sakanaka M; Wen TC; Matsuda S; Masuda S; Morishita E; Nagao M; Sasaki R
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4635-40. PubMed ID: 9539790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
